{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:26:57Z","timestamp":1793820417195,"version":"4.6.1"},"reference-count":237,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2024\\u20130466-01"],"award-info":[{"award-number":["2024\\u20130466-01"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024\\u201300339483"],"award-info":[{"award-number":["RS-2024\\u201300339483"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ctrv.2024.102808","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T06:42:19Z","timestamp":1722840139000},"page":"102808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-935X","authenticated-orcid":false,"given":"Ji-Hoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2024.102808_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12885-020-07749-6","article-title":"The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis","volume":"21","author":"Moslemi","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b0015","article-title":"Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0020","first-page":"7608","article-title":"Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients","volume":"61","author":"Dork","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001034","article-title":"ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage","volume":"3","author":"Bensimon","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.ctrv.2024.102808_b0035","doi-asserted-by":"crossref","first-page":"e104400","DOI":"10.15252\/embj.2020104400","article-title":"Phosphoproteomics reveals novel modes of function and inter-relationships among PIKKs in response to genotoxic stress","volume":"40","author":"Schlam-Babayov","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbiomolbio.2020.11.005","article-title":"Roles of ATM and ATR in DNA double strand breaks and replication stress","volume":"161","author":"Williams","year":"2021","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev-biochem-060614-034335","article-title":"Mechanisms of ATM Activation","volume":"84","author":"Paull","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ctrv.2024.102808_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.1192912","article-title":"ATM activation by oxidative stress","volume":"330","author":"Guo","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0060","first-page":"11","article-title":"Mitochondrial redox sensing by the kinase ATM maintains cellular antioxidant capacity","author":"Zhang","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.ctrv.2024.102808_b0065","first-page":"11","article-title":"ATM directs DNA damage responses and proteostasis via genetically separable pathways","author":"Lee","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.ctrv.2024.102808_b0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.devcel.2018.07.011","article-title":"Essential Function of Mec1, the Budding Yeast ATM\/ATR Checkpoint-Response Kinase, in Protein Homeostasis","volume":"46","author":"Corcoles-Saez","year":"2018","journal-title":"Dev Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/emboj.2010.330","article-title":"ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair","volume":"30","author":"Cosentino","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.dnarep.2013.11.002","article-title":"Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia","volume":"13","author":"Sharma","year":"2014","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ctrv.2024.102808_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/mt.2012.203","article-title":"Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia","volume":"21","author":"D\u2019Souza","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature14512","article-title":"The core spliceosome as target and effector of non-canonical ATM signalling","volume":"523","author":"Tresini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0095","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1128\/MCB.01125-06","article-title":"ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage","volume":"26","author":"Katzenberger","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0100","article-title":"Ataxia telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity","author":"Sarkar","year":"2020","journal-title":"Evidence from mantle cell lymphoma Haematologica"},{"key":"10.1016\/j.ctrv.2024.102808_b0105","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-021-00394-2","article-title":"Cellular functions of the protein kinase ATM and their relevance to human disease","author":"Lee","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2009.04.006","article-title":"Common mechanisms of PIKK regulation","volume":"8","author":"Lovejoy","year":"2009","journal-title":"DNA Repair"},{"key":"10.1016\/j.ctrv.2024.102808_b0120","doi-asserted-by":"crossref","first-page":"13436","DOI":"10.1074\/jbc.M115.708263","article-title":"The Dimeric Architecture of Checkpoint Kinases Mec1ATR and Tel1ATM Reveal a Common Structural Organization","volume":"291","author":"Sawicka","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.str.2019.10.012","article-title":"Cryo-EM Structure of Nucleotide-Bound Tel1ATM Unravels the Molecular Basis of Inhibition and Structural Rationale for Disease-Associated Mutations","volume":"28","author":"Yates","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.ctrv.2024.102808_b0130","doi-asserted-by":"crossref","first-page":"37538","DOI":"10.1074\/jbc.274.53.37538","article-title":"Substrate specificities and identification of putative substrates of ATM kinase family members","volume":"274","author":"Kim","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1126\/science.1108297","article-title":"ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex","volume":"308","author":"Lee","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0140","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1093\/emboj\/cdg541","article-title":"Requirement of the MRN complex for ATM activation by DNA damage","volume":"22","author":"Uziel","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0145","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1093\/emboj\/cdg630","article-title":"The Mre11 complex is required for ATM activation and the G2\/M checkpoint","volume":"22","author":"Carson","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature03442","article-title":"Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage","volume":"434","author":"Falck","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0155","doi-asserted-by":"crossref","unstructured":"Sun Y, Jiang X, Chen S, Fernandes N, Price BD. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proceedings of the National Academy of Sciences of the United States of America 2005;102:13182\u20137.","DOI":"10.1073\/pnas.0504211102"},{"key":"10.1016\/j.ctrv.2024.102808_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.01382-07","article-title":"DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity","volume":"27","author":"Sun","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0170","article-title":"Autophosphorylation and ATM activation: additional sites add to the complexity","volume":"286","author":"Kozlov","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0175","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1038\/sj.emboj.7601231","article-title":"Involvement of novel autophosphorylation sites in ATM activation","volume":"25","author":"Kozlov","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nsmb1090","article-title":"Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex","volume":"13","author":"Dupre","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0185","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.200805154","article-title":"Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo","volume":"183","author":"Daniel","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature05112","article-title":"Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo","volume":"443","author":"Pellegrini","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0195","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/15384101.2016.1158362","article-title":"Structure of the human dimeric ATM kinase","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molcel.2013.10.019","article-title":"Replication Stress and Chromatin Context Link ATM Activation to a Role in DNA Replication","volume":"52","author":"Olcina","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1091496","article-title":"Direct activation of the ATM protein kinase by the Mre11\/Rad50\/Nbs1 complex","volume":"304","author":"Lee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2012.02.018","article-title":"Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1","volume":"46","author":"Wu","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0215","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/MCB.25.13.5363-5379.2005","article-title":"ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1","volume":"25","author":"You","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/ncb1599","article-title":"Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair","author":"Berkovich","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0225","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0230","first-page":"5","article-title":"Double strand break repair functions of histone H2AX","volume":"750","author":"Scully","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0235","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","article-title":"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage","volume":"10","author":"Paull","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0240","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1158\/0008-5472.CAN-03-3207","article-title":"ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation","volume":"64","author":"Stiff","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0245","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jcp.20141","article-title":"Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors","volume":"202","author":"Wang","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ctrv.2024.102808_b0250","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2015.10.024","article-title":"Non-redundant Functions of ATM and DNA-PKcs in Response to DNA Double-Strand Breaks","volume":"13","author":"Caron","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.ctrv.2024.102808_b0255","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/nucl.11176","article-title":"The cellular response to DNA damage: a focus on MDC1 and its interacting proteins","volume":"1","author":"Coster","year":"2010","journal-title":"Nucleus"},{"key":"10.1016\/j.ctrv.2024.102808_b0260","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1073\/pnas.0802885105","article-title":"MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks","volume":"105","author":"Wu","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.ctrv.2024.102808_b0265","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.200708210","article-title":"Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin","author":"Melander","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0270","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.200709008","article-title":"Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin","author":"Spycher","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0275","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ncb1446","article-title":"Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway","volume":"8","author":"Ziv","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0280","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/BST0370569","article-title":"The impact of heterochromatin on DSB repair","volume":"37","author":"Goodarzi","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ctrv.2024.102808_b0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.molcel.2011.02.015","article-title":"Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks","volume":"41","author":"Moyal","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0290","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016410","article-title":"An Overview of the Molecular Mechanisms of Recombinational DNA Repair","volume":"7","author":"Kowalczykowski","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0295","doi-asserted-by":"crossref","unstructured":"You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, et al. CtIP links DNA double-strand break sensing to resection. Mol Cell 2009;36:954\u201369. https:\/\/doi.org\/S1097-2765(09)00905-8 [pii] 10.1016\/j.molcel.2009.12.002.","DOI":"10.1016\/j.molcel.2009.12.002"},{"key":"10.1016\/j.ctrv.2024.102808_b0300","doi-asserted-by":"crossref","first-page":"e1003277","DOI":"10.1371\/journal.pgen.1003277","article-title":"The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair","volume":"9","author":"Wang","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ctrv.2024.102808_b0305","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp1164","article-title":"Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks","author":"Bolderson","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0310","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1038\/sj.onc.1204003","article-title":"ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation","volume":"19","author":"Ababou","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2024.102808_b0315","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.286.5442.1162","article-title":"Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks","volume":"286","author":"Cortez","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0320","first-page":"4588","article-title":"Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation","volume":"62","author":"Xu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0325","first-page":"3299","article-title":"Role for ATM in DNA damage-induced phosphorylation of BRCA1","volume":"60","author":"Gatei","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.15252\/embr.201541455","article-title":"ATM\/ATR-mediated phosphorylation of PALB2 promotes RAD51 function","volume":"17","author":"Ahlskog","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ctrv.2024.102808_b0335","doi-asserted-by":"crossref","DOI":"10.1038\/nature06337","article-title":"Human CtIP promotes DNA end resection","author":"Sartori","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0340","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/emboj.2011.27","article-title":"Factors determining DNA double-strand break repair pathway choice in G2 phase","volume":"30","author":"Shibata","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0345","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-19-3126","article-title":"ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer","volume":"80","author":"Rafiei","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0350","article-title":"Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0355","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","article-title":"A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci","volume":"16","author":"Riballo","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0360","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/sj.emboj.7601255","article-title":"DNA-PK autophosphorylation facilitates Artemis endonuclease activity","volume":"25","author":"Goodarzi","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.ctrv.2024.102808_b0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2183\/pjab.90.365","article-title":"Ionizing radiation-induced XRCC4 phosphorylation is mediated through ATM in addition to DNA-PK","volume":"90","author":"Imamichi","year":"2014","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.ctrv.2024.102808_b0370","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.dnarep.2008.06.015","article-title":"DNA-PK and ATM phosphorylation sites in XLF\/Cernunnos are not required for repair of DNA double strand breaks","volume":"7","author":"Yu","year":"2008","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ctrv.2024.102808_b0375","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.dnarep.2017.01.004","article-title":"Regulation of human pol\u03bb by ATM-mediated phosphorylation during non-homologous end joining","volume":"51","author":"Sastre-Moreno","year":"2017","journal-title":"DNA Repair"},{"key":"10.1016\/j.ctrv.2024.102808_b0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2016.11.004","article-title":"Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM","volume":"65","author":"Zhou","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0385","doi-asserted-by":"crossref","unstructured":"Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008;31:167\u201377. https:\/\/doi.org\/S1097-2765(08)00395-X [pii] 10.1016\/j.molcel.2008.05.017.","DOI":"10.1016\/j.molcel.2008.05.017"},{"key":"10.1016\/j.ctrv.2024.102808_b0390","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1038\/ncomms4347","article-title":"ATM specifically mediates repair of double-strand breaks with blocked DNA ends","volume":"5","author":"\u00c1lvarez-Quil\u00f3n","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102808_b0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molcel.2011.03.019","article-title":"Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1","volume":"42","author":"Bothmer","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0400","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.molcel.2013.01.002","article-title":"RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection","volume":"49","author":"Chapman","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0405","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M113.457440","article-title":"RIF1 counteracts BRCA1-mediated end resection during DNA repair","volume":"288","author":"Feng","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0410","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1231573","article-title":"53BP1 regulates DSB repair using Rif1 to control 5\u2019 end resection","volume":"339","author":"Zimmermann","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0415","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1230624","article-title":"Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching","volume":"339","author":"Di Virgilio","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0420","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.cell.2013.05.023","article-title":"53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions","volume":"153","author":"Callen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0425","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1093\/nar\/gkaa723","article-title":"ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks","volume":"48","author":"Britton","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0430","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s42764-020-00017-8","article-title":"DNA double-strand break end resection: a critical relay point for determining the pathway of repair and signaling","volume":"1","author":"Katsuki","year":"2020","journal-title":"Genome Instab Dis"},{"key":"10.1016\/j.ctrv.2024.102808_b0435","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1297-453","article-title":"Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways","volume":"17","author":"Barlow","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2024.102808_b0440","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0445","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4161\/cc.9.3.10556","article-title":"Mechanism of p53 stabilization by ATM after DNA damage","volume":"9","author":"Cheng","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0450","doi-asserted-by":"crossref","unstructured":"Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587\u201397. https:\/\/doi.org\/10.1016\/0092-8674(92)90593-2.","DOI":"10.1016\/0092-8674(92)90593-2"},{"key":"10.1016\/j.ctrv.2024.102808_b0455","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1101\/gad.11.24.3471","article-title":"DNA damage induces phosphorylation of the amino terminus of p53","volume":"11","author":"Siliciano","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.ctrv.2024.102808_b0460","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","article-title":"Enhanced phosphorylation of p53 by ATM in response to DNA damage","volume":"281","author":"Banin","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0465","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0470","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35007091","article-title":"ATM phosphorylates p95\/nbs1 in an S-phase checkpoint pathway","volume":"404","author":"Lim","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0475","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1101\/gad.1200304","article-title":"Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway","volume":"18","author":"Kitagawa","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.ctrv.2024.102808_b0480","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","article-title":"The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis","volume":"410","author":"Falck","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0485","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1093\/nar\/8.16.3709","article-title":"Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells","volume":"8","author":"Houldsworth","year":"1980","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0490","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1073\/pnas.77.12.7315","article-title":"Radiosensitivity in ataxia-telangiectasia: a new explanation","volume":"77","author":"Painter","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ctrv.2024.102808_b0495","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/humu.20415","article-title":"Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry","volume":"27","author":"Bernstein","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ctrv.2024.102808_b0500","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/MCB.01139-10","article-title":"A cytosolic ATM\/NEMO\/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)\/MAPK-activated protein 2 responses to DNA damage","volume":"31","author":"Yang","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0505","doi-asserted-by":"crossref","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0510","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4161\/cbt.23761","article-title":"Chemotherapy induced DNA damage response: convergence of drugs and pathways","volume":"14","author":"Woods","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0515","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2014.12.001","article-title":"ATM and ATR as therapeutic targets in cancer","volume":"149","author":"Weber","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0520","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","article-title":"DNA double-strand break repair-pathway choice in somatic mammalian cells","volume":"20","author":"Scully","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0525","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/onc.2013.275","article-title":"ATM signalling and cancer","volume":"33","author":"Cremona","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2024.102808_b0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b0535","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","article-title":"Neoplasia, untoward response to x-irradiation, and tuberous sclerosis","volume":"114","author":"Gotoff","year":"1967","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ctrv.2024.102808_b0540","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/258427a0","article-title":"Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity","volume":"258","author":"Taylor","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0545","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b0550","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/09553008114550651","article-title":"Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation","volume":"39","author":"Zampetti-Bosseler","year":"1981","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"10.1016\/j.ctrv.2024.102808_b0555","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0027-5107(83)90054-4","article-title":"Comparison of kinetics of X-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts","volume":"109","author":"Nagasawa","year":"1983","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0560","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-2797(83)90167-9","article-title":"Responses of Huntington\u2019s disease and ataxia telangiectasia lymphoblastoid cells to bleomycin","volume":"47","author":"Imray","year":"1983","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ctrv.2024.102808_b0565","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2024.102808_b0570","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1383-5742(00)00034-X","article-title":"The ATM gene and breast cancer: is it really a risk factor?","volume":"462","author":"Ang\u00e8le","year":"2000","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0580","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers","volume":"14","author":"Hall","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ctrv.2024.102808_b0585","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0590","first-page":"3325","article-title":"Contributions of ATM mutations to familial breast and ovarian cancer","volume":"63","author":"Thorstenson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0595","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1158\/1055-9965.EPI-10-0374","article-title":"Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls","volume":"19","author":"Fletcher","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2024.102808_b0600","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jcp.54.7.512","article-title":"Ataxia telangiectasia gene mutations in leukaemia and lymphoma","volume":"54","author":"Boultwood","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ctrv.2024.102808_b0605","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.onc.1201603","article-title":"ATM is usually rearranged in T-cell prolymphocytic leukaemia","volume":"16","author":"Yuille","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2024.102808_b0610","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2024.102808_b0615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2021.09.008","article-title":"Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients","volume":"32","author":"Garc\u00eda","year":"2022","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b0620","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0625","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Gorgoulis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0630","doi-asserted-by":"crossref","DOI":"10.1038\/nature05268","article-title":"Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints","volume":"444","author":"Bartkova","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0635","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication","volume":"444","author":"Di Micco","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0640","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0645","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/0008-5472.CAN-19-1807","article-title":"Therapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance","volume":"80","author":"Rezaeian","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0655","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/gut.2009.189720","article-title":"CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer","volume":"59","author":"Ripka","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ctrv.2024.102808_b0660","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/0008-5472.CAN-11-3386","article-title":"Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression","volume":"72","author":"Pazolli","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0665","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncb3445","article-title":"A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1\u03b1 activation, tumorigenesis and metastasis","volume":"19","author":"Rezaeian","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2010.10.030","article-title":"mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha","volume":"40","author":"Cam","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0675","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1073\/pnas.0912710107","article-title":"HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis","volume":"107","author":"Hayashida","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ctrv.2024.102808_b0680","doi-asserted-by":"crossref","first-page":"e39446","DOI":"10.1371\/journal.pone.0039446","article-title":"Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2024.102808_b0685","doi-asserted-by":"crossref","unstructured":"Chiba N, Comaills V, Shiotani B, Takahashi F, Shimada T, Tajima K, et al. Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses. Proceedings of the National Academy of Sciences of the United States of America 2012;109:2760\u20135. https:\/\/doi.org\/10.1073\/pnas.1018867108.","DOI":"10.1073\/pnas.1018867108"},{"key":"10.1016\/j.ctrv.2024.102808_b0690","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.28245","article-title":"Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker","volume":"134","author":"Kim","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b0695","doi-asserted-by":"crossref","first-page":"eadg2263","DOI":"10.1126\/sciadv.adg2263","article-title":"ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer","volume":"9","author":"Zhou","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.ctrv.2024.102808_b0700","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0705","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/1535-7163.MCT-09-0872","article-title":"ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors","volume":"9","author":"Williamson","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0710","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1124\/mol.105.012716","article-title":"Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival","volume":"68","author":"Karnitz","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ctrv.2024.102808_b0715","doi-asserted-by":"crossref","first-page":"e1000324","DOI":"10.1371\/journal.pgen.1000324","article-title":"ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress","volume":"5","author":"Myers","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ctrv.2024.102808_b0720","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1038\/ncomms8677","article-title":"Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition","volume":"6","author":"Russell","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102808_b0725","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccr.2010.10.034","article-title":"Loss of ATM\/Chk2\/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas","volume":"18","author":"Squatrito","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0730","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fgene.2020.00933","article-title":"ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment","volume":"11","author":"Yi","year":"2020","journal-title":"Front Genet"},{"issue":"e139333","key":"10.1016\/j.ctrv.2024.102808_b0735","article-title":"ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation","volume":"131","author":"Hu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2024.102808_b0740","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","article-title":"Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0745","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0750","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b0755","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.3390\/biom5042877","article-title":"ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor","volume":"5","author":"Lavin","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctrv.2024.102808_b0760","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20102162","article-title":"ATR signalling: more than meeting at the fork","volume":"436","author":"Nam","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.ctrv.2024.102808_b0765","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G","article-title":"Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history","volume":"92","author":"Teraoka","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b0770","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","article-title":"Cancer risks among BRCA1 and BRCA2 mutation carriers","volume":"96","author":"Levy-Lahad","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b0775","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b0780","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/genetics\/31.3.269","article-title":"Genetics of natural populations; recombination and variability in populations of Drosophila pseudoobscura","volume":"31","author":"Dobzhansky","year":"1946","journal-title":"Genetics"},{"key":"10.1016\/j.ctrv.2024.102808_b0785","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM Mutations in Cancer: Therapeutic Implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0790","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM","author":"Hickson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0795","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/09553002.2015.1001531","article-title":"The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect","volume":"91","author":"Zhang","year":"2015","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0800","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion","volume":"8","author":"Golding","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0805","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation","volume":"19","author":"Biddlestone-Thorpe","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0810","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1535-7163.MCT-12-0707","article-title":"Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer","volume":"12","author":"Batey","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0815","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-08-0763","article-title":"Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation","volume":"68","author":"Rainey","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0820","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2017.08.013","article-title":"DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy","volume":"60","author":"Carrassa","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2024.102808_b0825","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1535-7163.MCT-21-0934","article-title":"A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies","volume":"21","author":"Zimmermann","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0830","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-018-07729-2","article-title":"ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks","volume":"10","author":"Balmus","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102808_b0835","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b0840","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-14-3502","article-title":"Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM","volume":"75","author":"McCabe","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0845","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13701","article-title":"MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated","author":"Smida","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102808_b0850","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tranon.2017.01.007","article-title":"ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib","volume":"10","author":"Wang","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b0855","article-title":"Mechanisms of CDK4\/6 Inhibitor Resistance in Luminal Breast Cancer","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ctrv.2024.102808_b0860","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1158\/1078-0432.CCR-17-3702","article-title":"Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers","volume":"24","author":"Anurag","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0865","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/2159-8290.CD-16-1179","article-title":"Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4\/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer","volume":"7","author":"Haricharan","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ctrv.2024.102808_b0870","doi-asserted-by":"crossref","first-page":"44289","DOI":"10.18632\/oncotarget.6247","article-title":"The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo","volume":"6","author":"Vendetti","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2024.102808_b0875","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2015-05-644872","article-title":"ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells","volume":"127","author":"Kwok","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2024.102808_b0880","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.4161\/15384101.2014.960729","article-title":"Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents","volume":"13","author":"Cui","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0885","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.2017.75.7740","article-title":"Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1\/PD-L1 Blockade in Advanced Urothelial Cancers","volume":"36","author":"Teo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b0890","article-title":"A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response","volume":"3","author":"Weir","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ctrv.2024.102808_b0895","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ymgme.2003.09.008","article-title":"Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression","volume":"80","author":"Chun","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ctrv.2024.102808_b0900","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4161\/cc.10.7.15231","article-title":"A minimally invasive assay for individual assessment of the ATM\/CHEK2\/p53 pathway activity","volume":"10","author":"Kabacik","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0905","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/genes12050727","article-title":"The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice","volume":"12","author":"Stucci","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ctrv.2024.102808_b0910","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4161\/cc.9.20.13471","article-title":"Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors","volume":"9","author":"Choi","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0915","doi-asserted-by":"crossref","unstructured":"White JS, Choi S, Bakkenist CJ. Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange. Science Signaling n.d.;3:ra44. https:\/\/doi.org\/3\/124\/ra44 [pii] 10.1126\/scisignal.2000758.","DOI":"10.1126\/scisignal.2000758"},{"key":"10.1016\/j.ctrv.2024.102808_b0920","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1083\/jcb.201204098","article-title":"Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice","volume":"198","author":"Yamamoto","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0925","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cc.5.1.2269","article-title":"ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity","volume":"5","author":"Oricchio","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b0930","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2012.06.024","article-title":"PIDD Death-Domain Phosphorylation by ATM Controls Prodeath versus Prosurvival PIDDosome Signaling","volume":"47","author":"Ando","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b0935","doi-asserted-by":"crossref","first-page":"e25454","DOI":"10.1371\/journal.pone.0025454","article-title":"miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase","volume":"6","author":"Song","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2024.102808_b0940","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tibs.2009.09.005","article-title":"WIP1 phosphatase at the crossroads of cancer and aging","volume":"35","author":"Le Guezennec","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ctrv.2024.102808_b0945","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1158\/1535-7163.MCT-12-0448","article-title":"Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer","volume":"11","author":"Wang","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b0950","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1087057113520325","article-title":"Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors","volume":"19","author":"Guo","year":"2014","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.ctrv.2024.102808_b0955","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1074\/jbc.M212360200","article-title":"ATR\/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation","volume":"278","author":"Hammond","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b0960","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.dnarep.2006.01.011","article-title":"DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells","volume":"5","author":"Mukherjee","year":"2006","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ctrv.2024.102808_b0965","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nchembio.573","article-title":"Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR","volume":"7","author":"Reaper","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0970","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/0008-5472.CAN-12-2929","article-title":"Targeting XRCC1 deficiency in breast cancer for personalized therapy","volume":"73","author":"Sultana","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b0975","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI31245","article-title":"Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated","volume":"117","author":"Kennedy","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2024.102808_b0980","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nsmb.2076","article-title":"A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations","volume":"18","author":"Toledo","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0985","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nsmb.2189","article-title":"Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors","volume":"18","author":"Murga","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b0990","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI58928","article-title":"Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR","volume":"122","author":"Schoppy","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2024.102808_b0995","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.1257216","article-title":"Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors","volume":"347","author":"Flynn","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2024.102808_b1000","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","author":"Durant","year":"2018","journal-title":"Sci Adv"},{"issue":"e142158","key":"10.1016\/j.ctrv.2024.102808_b1005","article-title":"Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models","volume":"131","author":"Deland","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2024.102808_b1010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/djaa095","article-title":"Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy","volume":"113","author":"Pitter","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2024.102808_b1015","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cncr.22592","article-title":"Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival","volume":"109","author":"Ye","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b1020","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/sj.onc.1210885","article-title":"The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1\/BRCA2-deficient and ER\/PR\/ERBB2-triple-negative breast cancer","volume":"27","author":"Tommiska","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2024.102808_b1025","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.bjc.6601804","article-title":"Abnormality of the DNA double-strand-break checkpoint\/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade","volume":"90","author":"Ding","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b1030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.eururo.2020.10.029","article-title":"Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors","volume":"79","author":"Neeb","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2024.102808_b1035","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1158\/1078-0432.CCR-20-0764","article-title":"Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer","volume":"26","author":"Kaur","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAI.0000000000000786","article-title":"Development of an Immunohistochemical Assay to Detect the Ataxia-Telangiectasia Mutated (ATM) Protein in Gastric Carcinoma","volume":"28","author":"Miller","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ctrv.2024.102808_b1045","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1158\/1078-0432.CCR-16-0247","article-title":"Biomarkers of Response and Resistance to DNA Repair Targeted Therapies","volume":"22","author":"Stover","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2024.102808_b1055","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/ijc.27488","article-title":"The role of ATM and 53BP1 as predictive markers in cervical cancer","volume":"131","author":"Roossink","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b1060","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1158\/0008-5472.CAN-13-3229","article-title":"ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency","volume":"74","author":"Mohni","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1065","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4161\/cc.29212","article-title":"Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines","volume":"13","author":"Kubota","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b1070","doi-asserted-by":"crossref","first-page":"e24080","DOI":"10.1371\/journal.pone.0024080","article-title":"The phenotypic radiation resistance of CD44+\/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling","volume":"6","author":"Yin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2024.102808_b1075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2007.04.012","article-title":"Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy","volume":"69","author":"Ho","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2024.102808_b1080","article-title":"Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants. JCO Precis","volume":"5","author":"Modlin","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.ctrv.2024.102808_b1085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-021-08085-z","article-title":"Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)","volume":"21","author":"Grivas","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2024.102808_b1090","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41591-021-01317-6","article-title":"An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer","volume":"27","author":"Powles","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2024.102808_b1095","doi-asserted-by":"crossref","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b1100","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1038\/ncomms7886","article-title":"ATM kinase sustains HER2 tumorigenicity in breast cancer","volume":"6","author":"Stagni","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102808_b1105","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2024.102808_b1110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cge.12710","article-title":"Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline","volume":"90","author":"van Os","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.ctrv.2024.102808_b1115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gepi.21971","article-title":"Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk","volume":"40","author":"Marabelli","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.ctrv.2024.102808_b1120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/humu.20805","article-title":"Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk","volume":"30","author":"Mitui","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ctrv.2024.102808_b1125","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/0008-5472.CAN-08-0088","article-title":"Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance","volume":"68","author":"Swisher","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2024.102808_b1135","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1038\/sj.onc.1210872","article-title":"Activation and regulation of ATM kinase activity in response to DNA double-strand breaks","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2024.102808_b1140","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M410344200","article-title":"Full activation of PKB\/Akt in response to insulin or ionizing radiation is mediated through ATM","volume":"280","author":"Viniegra","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2024.102808_b1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2008.04.011","article-title":"ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells","volume":"20","author":"Halaby","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.ctrv.2024.102808_b1150","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-08-1189","article-title":"The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt","volume":"9","author":"Li","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2024.102808_b1155","doi-asserted-by":"crossref","DOI":"10.4161\/cc.10.13.16305","article-title":"MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks","volume":"10","author":"Fraser","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b1160","doi-asserted-by":"crossref","DOI":"10.4161\/cc.10.3.14713","article-title":"ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks","volume":"10","author":"Khalil","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2024.102808_b1165","doi-asserted-by":"crossref","DOI":"10.1038\/cr.2010.179","article-title":"Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage","volume":"21","author":"Miyamoto","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1170","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.CAN-09-2715","article-title":"Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability","volume":"70","author":"Pires","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102808_b1175","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00347-10","article-title":"Requirement of the ATM\/p53 tumor suppressor pathway for glucose homeostasis","volume":"30","author":"Armata","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2024.102808_b1180","doi-asserted-by":"crossref","DOI":"10.1038\/nm1320","article-title":"The antioxidant function of the p53 tumor suppressor","volume":"11","author":"Sablina","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2024.102808_b1185","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-2287-2","article-title":"p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis","volume":"64","author":"Hussain","year":"2004","journal-title":"Cancer Res"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:20:37Z","timestamp":1778685637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737224001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":237,"alternative-id":["S0305737224001361"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102808","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102808"}}